KAS
ABBV icon

Kestra Advisory Services’s AbbVie ABBV Stock Holding History

Kestra Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.9M Buy
431,581
+20,714
+5% +$4.59M 0.36% 46
2025
Q4 		$93.9M Buy
410,867
+19,253
+5% +$4.39M 0.39% 43
2025
Q3 		$90.7M Buy
391,614
+40,288
+11% +$8.2M 0.41% 36
2025
Q2 		$65.2M Buy
351,326
+12,671
+4% +$2.35M 0.32% 50
2025
Q1 		$71M Sell
338,655
-8,507
-2% -$1.65M 0.34% 33
2024
Q4 		$61.7M Sell
347,162
-7,607
-2% -$1.4M 0.34% 53
2024
Q3 		$70.1M Sell
354,769
-17,681
-5% -$3.3M 0.39% 39
2024
Q2 		$63.9M Buy
372,450
+66,345
+22% +$11M 0.36% 45
2024
Q1 		$55.7M Buy
306,105
+16,994
+6% +$2.93M 0.37% 39
2023
Q4 		$44.8M Buy
289,111
+5,962
+2% +$869K 0.36% 45
2023
Q3 		$42.2M Sell
283,149
-53,877
-16% -$7.91M 0.42% 37
2023
Q2 		$45.4M Buy
337,026
+41,499
+14% +$6.09M 0.45% 31
2023
Q1 		$47.1M Sell
295,527
-60,875
-17% -$9.31M 0.51% 28
2022
Q4 		$57.6M Sell
356,402
-1,563
-0.4% -$240K 0.51% 28
2022
Q3 		$48M Buy
357,965
+69,687
+24% +$10M 0.51% 26
2022
Q2 		$44.2M Buy
288,278
+15,852
+6% +$2.42M 0.45% 33
2022
Q1 		$44.2M Sell
272,426
-56,292
-17% -$8.18M 0.46% 33
2021
Q4 		$44.5M Sell
328,718
-6,828
-2% -$807K 0.45% 34
2021
Q3 		$36.2M Buy
335,546
+24,493
+8% +$2.8M 0.36% 51
2021
Q2 		$35M Buy
311,053
+5,411
+2% +$609K 0.4% 43
2021
Q1 		$33.1M Buy
305,642
+7,785
+3% +$833K 0.42% 40
2020
Q4 		$31.4M Buy
297,857
+65,546
+28% +$6.3M 0.36% 52
2020
Q3 		$20.4M Buy
+232,311
New +$21.9M 0.38% 49

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kestra Advisory Services's ABBV Position: Q1 2026 in Review

Kestra Advisory Services increased its AbbVie (ABBV) stake by 5% in Q1 2026, buying an estimated $4.59M and bringing the position to 431,581 shares worth $93.9M. The position accounts for 0.36% of the portfolio, ranked #46.

Kestra Advisory Services first reported a position in ABBV in Q3 2020 and has held it in 23 quarters since. The position peaked at $93.9M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Kestra Advisory Services held 431,581 shares of AbbVie worth $93.9M as of Q1 2026.
  • Kestra Advisory Services bought 20,714 AbbVie shares in Q1 2026, an estimated $4.59M.
  • AbbVie made up 0.36% of Kestra Advisory Services's portfolio in Q1 2026, its #46 holding.
  • Kestra Advisory Services first reported a position in AbbVie in Q3 2020 and has held it in 23 quarters since.
  • Kestra Advisory Services's AbbVie position peaked at $93.9M in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.